1. Home
  2. Investing
  3. Stocks
  4. USA
  6. Protagonist Therapeutics Inc (PTGX)
  7. Quote


Protagonist Therapeutics Stock Price

-0.42 (-1.28%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 476,807
Bid Price 30.70
Ask Price 35.31
News (1)
Day High 33.17


52 Week Range


Day Low 31.79
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Protagonist Therapeutics Inc PTGX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.42 -1.28% 32.27 18:00:04
Open Price Low Price High Price Close Price Prev Close
32.68 31.79 33.17 32.27 32.69
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
6,352 476,807 $ 32.48 $ 15,488,374 - 12.80 - 50.54
Last Trade Time Type Quantity Stock Price Currency
19:18:59 1 $ 32.27 USD


Draw Mode:

Protagonist Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.54B 47.73M 38.12M $ 28.63M $ - -1.99 -12.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -14.78k 1.50%

more financials information »

Protagonist Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PTGX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week33.2934.9130.7532.35476,569-1.02-3.06%
1 Month33.9438.1130.7534.86560,020-1.67-4.92%
3 Months45.9347.2812.8027.142,113,023-13.66-29.74%
6 Months35.6350.5412.8030.431,197,495-3.36-9.43%
1 Year21.6850.5412.8029.20801,23510.5948.85%
3 Years6.7850.544.4721.44520,33525.49375.96%
5 Years25.1250.544.4719.93371,3017.1528.46%

Protagonist Therapeutics Description

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidate to address medical needs.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.